Home » Topics » Conferences

Conferences
RSS

Novel zebrafish model of Opa1-mutated dominant optic atrophy

May 17, 2022

STK-002 confers a dose-dependent increase in OPA1 expression in ADOA retina

May 17, 2022

Hyaluronidase-expressing oncolytic virus VCN-11 shows promise as cancer immunotherapeutic

May 17, 2022

SHP-2 inhibitor NSC-87877 ameliorates clinical symptoms of MuSK-induced myasthenia gravis

May 16, 2022

AMP vaccine boosting enhances TCR-T cell therapy in mice with solid tumors

May 16, 2022

MuSK-CAARTs demonstrate promising safety and activity in models of MuSK myasthenia gravis

May 16, 2022

miR30e-5p is a predictive biomarker of relapse in myasthenia gravis

May 16, 2022

Large animal model of USH3 disease generated by zygote injection and guide RNAs

May 16, 2022

CCL22-derived peptides as vaccines for cancer immunotherapy

May 16, 2022

Novel CAR-NK cells targeting CD33 show promise for AML

May 16, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...